Our current findings agree with those from other reports showing that β2M is an effective growth-promoting factor in the growth and progression of renal cell carcinoma and prostate cancer (Huang et al, 2006; Nomura et al, 2006). This evidence concerns the gene B2M and prostate carcinoma.